Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis. - Wikidata - awgldk - TriplyDB

Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis.

Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis.

http://www.wikidata.org/entity/Q41586844

about

Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells Extracellular 3',5'-cAMP-adenosine pathway inhibits glomerular mesangial cell growth.Connexin43 hemichannels contribute to cadmium-induced oxidative stress and cell injury.Eviprostat activates cAMP signaling pathway and suppresses bladder smooth muscle cell proliferation.Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells.Irsogladine maleate inhibits Porphyromonas gingivalis-mediated expression of toll-like receptor 2 and interleukin-8 in human gingival epithelial cells.Effect of L-arginine supplement on liver regeneration after partial hepatectomy in rats.Disruption of gap junctions attenuates aminoglycoside-elicited renal tubular cell injury.Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP.

P2860

Q28569184-EF7B8A93-C218-4231-B172-050988702353 Q33890867-DF9245CC-5A0B-4DDC-A5E8-D6349674510B Q34987228-A0C6E333-4C88-4C09-8CF5-9CC2595554A3 Q37007292-0EF14343-18F6-4B32-AABD-8101FB2D548B Q37193830-1B3379F2-F2E5-425A-8492-1F70A8D099DB Q38954282-EC012A05-E13F-464E-ACDE-A44EF1C52490 Q42086739-9F99B6A1-62B9-4EC4-B3FE-CBFD3242BDEF Q42407358-748AB356-C81E-4851-AF93-01D6B1A14BD5 Q46289411-49EAC01C-3B94-47D8-8B40-64DB58A27F34

P2860

Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis.

http://www.wikidata.org/entity/Q41586844

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Irsogladine maleate potentiate ...... of mesangial cell mitogenesis.

@en

type

label

Irsogladine maleate potentiate ...... of mesangial cell mitogenesis.

@en

prefLabel

Irsogladine maleate potentiate ...... of mesangial cell mitogenesis.

@en

P1433

Q41586844-BEA066CC-BC38-41A6-9D58-79EC6DB18BDE

P1476

Q41586844-6BD3AA75-229B-413E-A874-6B73BA294F68

P2093

Q41586844-106D8205-30AD-44D4-B141-CE8F2E25D2AC

Q41586844-211BFBFD-4906-4931-833B-44655454D8E6

Q41586844-41CB85D7-10BD-4E33-848F-8E656FAA39E1

Q41586844-AB54495C-D0F0-4373-82B7-035DB37541B5

Q41586844-ABE2FBE4-5A9A-4814-B958-4FB3D64E4CB6

Q41586844-C4CC5C2E-065A-4C95-A0E8-57FE5AF3DC53

Q41586844-E1ABA216-5BA7-4810-8FD0-08E1FD80C91F

P2860

Q41586844-08C9C974-33CF-4F62-A05C-0076F2BD8717

Q41586844-09FCF4AC-8290-4AB4-AAA9-47E0AFBC913B

Q41586844-0C7A3E54-42E2-4125-8DA2-48EACCAF2726

Q41586844-0F707640-9804-49CA-B3E1-97A1965E2DEE

Q41586844-343D7862-D3AC-44F9-9FCF-EDB769CA2573

Q41586844-36E1DF44-0313-4689-AC70-DE5D1BD47032

Q41586844-398226DB-6EAC-446A-82FE-23A5C6954364

Q41586844-55E9D0BC-D7F7-4E73-9735-CE810081AECA

Q41586844-581D0E5F-A88E-4343-BC99-9093DB970ECE

Q41586844-6136DA91-3EAC-4722-8EF4-AC7BC8B78A48

P304

Q41586844-E4F3561B-A29E-4582-8BA8-F3DA419B5064

P31

Q41586844-10ADCDC7-1C85-4B67-802E-6F4A4A90581D

P356

Q41586844-9F7459C1-59B6-43E4-A582-F1CED23CDE28

P407

Q41586844-2A16EF3E-0BD3-4291-896A-7DF968AC12EE

P433

Q41586844-46F2BC59-BB2C-4F86-9C26-11AF2814C7A7

P478

Q41586844-CA4907B1-60CD-4CF3-BA0B-029C06949FC8

P577

Q41586844-961ABB59-8B1E-4864-BD69-4FFA23E52C47

P5875

Q41586844-2EB9E2F7-BC6D-4A84-8727-9ABB89F7578E

P698

Q41586844-6C607067-90B5-4A15-9B1F-0CBCE01BD191

P932

Q41586844-586C0FE0-7707-4A1E-9600-40BAAAC64217

P356

P1433

British Journal of Pharmacology

P1476

Irsogladine maleate potentiate ...... of mesangial cell mitogenesis.

@en

P2093

Hiramatsu N

http://www.w3.org/2001/XMLSchema#string

Kitamura M

http://www.w3.org/2001/XMLSchema#string

Sawada N

http://www.w3.org/2001/XMLSchema#string

Sun W

http://www.w3.org/2001/XMLSchema#string

Takeda M

http://www.w3.org/2001/XMLSchema#string

Yao J

http://www.w3.org/2001/XMLSchema#string

Zhu Y

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

Physiology and pathophysiology of nitric oxide in chronic renal disease.

Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 beta-stimulated rat mesangial cells.

Nitric oxide inhibition and renal alterations.

Nitric oxide modulates vascular disease in the remnant kidney model.

Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells.

L-arginine as a therapeutic tool in kidney disease.

Nitric oxide inhibits growth of glomerular mesangial cells: role of the transcription factor EGR-1.

P304

457-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0707255

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6392279

http://www.w3.org/2001/XMLSchema#string

P698

17435794

http://www.w3.org/2001/XMLSchema#string

P932

2013962

http://www.w3.org/2001/XMLSchema#string